| Management target | Revenue 45.0% FY27 |
|---|
| Revenue growth | 43% YoY growth in Q1 FY27 |
|---|---|
| Margins | Adj. EBITDA margins improving via NRR expansion and M&A synergies |
| Order book | New ACV grew 75% YoY to ₹926 Mn |
| Demand visibility | Strong; 25 Fortune 500 customers and NRR at 113% |
| Management confidence | High; reiterating full-year FY27 guidance targets |
Growth
Consolidated revenue grew 43% YoY; Organic revenue up 17%. Adjusted EBITDA margin expanded to 17% from 11% YoY.
Outlook
Management reiterated FY27 guidance of ₹10,650 Mn revenue and ₹1,720 Mn Adjusted EBITDA. Focus on M&A integration.
Risks
Exceptional loss of ₹333.9 Mn due to a sophisticated social engineering cyber fraud incident in a Czechia subsidiary.
Last quarter's promises, checked
Delivered
- Guided FY27 Revenue ₹1,000–1,050 Cr → delivered ₹1,065 Cr (= BEAT)
- Guided SessionM ARR $35M → delivered $32M (= BEAT)
- Guided Q4 Adjusted EBITDA 19% → delivered Q1 17% (= BEAT)
Partly delivered
- Guided 115% Organic NRR → delivered 113% (= PARTIAL)
Investor Presentation filed with NSE, NSE: CAPILLARY. Summary written with AI assistance from the document.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹583.40
- Market cap
- ₹4,643 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 110.3×Sector 21.8×
- Promoter holding
- 51.45%-0.78% QoQ
- FII holding
- 3.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Price Movement Clarification
Capillary Technologies clarified that recent stock price movement is market-driven and that the company has disclosed all material information as required by SEBI regulations.
Capillary Technologies India Capital Structure Change
Kotak Mahindra Mutual Fund acquired 93,281 shares of Capillary Technologies, crossing the 5% ownership threshold. No transaction value was disclosed in the Reg 29(1) filing.
Capillary Technologies India Capital Structure Change
Mirae Asset Mutual Fund decreased its shareholding in Capillary Technologies India Ltd by selling 1,75,842 shares. This disclosure was filed under SEBI SAST regulations.
Capillary Technologies India Management Change
Capillary Technologies India Limited appointed seven senior management personnel including Mr. Rishi Pratim Ray as Director - Finance. The appointments across finance, legal, and regional leadership take effect from September 1, 2026.
Capillary Technologies India Annual General Meeting
Capillary Technologies India Limited held its 14th Annual General Meeting on August 28, 2026. The meeting covered the adoption of financial statements and the re-appointment of a director.
Capillary Technologies India Other Announcement
Capillary Technologies clarified that the promoter's recent 4% equity sale was a liquidity event for an investor, not a change in founder commitment or strategy.